These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19101405)

  • 1. First-line combination treatment of colorectal cancer with hepatic metastases: choosing a targeted agent.
    Lenz HJ
    Cancer Treat Rev; 2008; 34 Suppl 2():S3-7. PubMed ID: 19101405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for colorectal cancer liver metastases.
    Alberts SR; Wagman LD
    Oncologist; 2008 Oct; 13(10):1063-73. PubMed ID: 18838438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
    Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
    Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated options for liver-limited metastatic colorectal cancer.
    Alberts SR
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
    Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
    Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of biological agents in the resection of colorectal liver metastases.
    Nordlinger B; Adam R; Arnold D; Zalcberg JR; Gruenberger T
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):432-42. PubMed ID: 22794325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
    Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
    Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of the I-colic time in colorectal cancer with synchronous hepatic metastases. Specifics of surgical strategy].
    Moldovan B; Copotoiu C; Bud V; Nemes I; Serac G; Molnar C; Florea S; Cornăteanu S; Milutin D; Coţovanu A; Pocreaţă D
    Chirurgia (Bucur); 2008; 103(5):539-46. PubMed ID: 19260629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second-line chemotherapy for colorectal cancer].
    Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
    Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
    Abdalla EK; Vauthey JN
    Dig Surg; 2008; 25(6):421-9. PubMed ID: 19212114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.
    Neumann UP; Thelen A; Röcken C; Seehofer D; Bahra M; Riess H; Jonas S; Schmeding M; Pratschke J; Bova R; Neuhaus P
    Surgery; 2009 Jul; 146(1):52-9. PubMed ID: 19541010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable liver metastases from colorectal cancer and hepatic arterial infusion chemotherapy: how, when and to whom?
    Viúdez A; Rodríguez J; Gil-Bazo I
    Cardiovasc Intervent Radiol; 2009 May; 32(3):603-4. PubMed ID: 19194743
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.
    Kim JC; Shin ES; Kim CW; Roh SA; Cho DH; Na YS; Kim TW; Kim MB; Hyun YL; Ro S; Kim SY; Kim YS
    Anticancer Res; 2009 Aug; 29(8):3027-34. PubMed ID: 19661311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis?
    Kerr DJ
    Nat Clin Pract Oncol; 2006 Sep; 3(9):480-1. PubMed ID: 16955085
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?
    Adam R; Wicherts DA; de Haas RJ; Ciacio O; Lévi F; Paule B; Ducreux M; Azoulay D; Bismuth H; Castaing D
    J Clin Oncol; 2009 Apr; 27(11):1829-35. PubMed ID: 19273699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.